Earnings Per Share |
Earnings Per Share Basic Earnings Per Share We calculate basic earnings per share by dividing the net income for the period attributable to shareholders of the Parent by the weighted average number of shares outstanding. | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, 2017 |
| | June 30, 2018 |
| | June 30, 2017 |
| | June 30, 2018 |
| | | (in thousands, except share amount and per data) | Net income attributable to shareholders of Criteo S.A. | | $ | 5,970 |
| | $ | 13,726 |
| | $ | 18,411 |
| | $ | 33,535 |
| Weighted average number of shares outstanding | | 65,027,985 |
| | 66,347,599 |
| | 64,611,237 |
| | 66,254,476 |
| Basic earnings per share | | $ | 0.09 |
| | $ | 0.21 |
| | $ | 0.28 |
| | $ | 0.51 |
|
Diluted Earnings Per Share We calculate diluted earnings per share by dividing the net income attributable to shareholders of the Parent by the weighted average number of shares outstanding plus any potentially dilutive shares not yet issued from share-based compensation plans (see Note 10). There were no other potentially dilutive instruments outstanding as of June 30, 2017 and 2018. Consequently, all potential dilutive effects from shares are considered. For each period presented, a contract to issue a certain number of shares (i.e. share option, non-employee warrant ("BSA"), restricted share unit ("RSU") or employee warrant ("BSPCE") is assessed as potentially dilutive if it is “in the money” (i.e., the exercise or settlement price is lower than the average market price). | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, 2017 |
| | June 30, 2018 |
| | June 30, 2017 |
| | June 30, 2018 |
| | | (in thousands, except share amount and per data) | Net income attributable to shareholders of Criteo S.A. | | $ | 5,970 |
| | $ | 13,726 |
| | $ | 18,411 |
| | $ | 33,535 |
| Weighted average number of shares outstanding of Criteo S.A. | | 65,027,985 |
| | 66,347,599 |
| | 64,611,237 |
| | 66,254,476 |
| Dilutive effect of : | |
| |
| |
| |
| Restricted share awards ("RSUs") | | 1,598,093 |
| | 721,154 |
| | 1,438,010 |
| | 793,096 |
| Share options and BSPCE | | 1,427,448 |
| | 382,066 |
| | 1,574,728 |
| | 394,936 |
| Share warrants | | 77,748 |
| | 37,492 |
| | 85,814 |
| | 37,005 |
| Weighted average number of shares outstanding used to determine diluted earnings per share | | 68,131,274 |
| | 67,488,311 |
| | 67,709,789 |
| | 67,479,513 |
| Diluted earnings per share | | $ | 0.09 |
| | $ | 0.20 |
| | $ | 0.27 |
| | $ | 0.50 |
|
The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows: | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, 2017 | | June 30, 2018 | | June 30, 2017 | | June 30, 2018 | | | | | | | | | | Restricted share awards | | 11,834 |
| | 2,651,262 |
| | 120,782 |
| | 2,276,195 |
| Share options and BSPCE | | 129,005 |
| | — |
| | 285,958 |
| | — |
| Weighted average number of anti-dilutive securities excluded from diluted earnings per share | | 140,839 |
| | 2,651,262 |
| | 406,740 |
| | 2,276,195 |
|
|